Home > Journals > Medicine > Bulletin du cancer > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Bulletin du Cancer
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

BTG2, its family and its tutor


Bulletin du Cancer. Volume 91, Number 7, 10242-53, Juillet - Août 2004, Electronic journal of oncology

Free Article  

Author(s) : Cyril DURIEZ, Caroline MOYRET-LALLE, Nicole FALETTE, Fatiha EL-GHISSASSI, Alain PUISIEUX

Summary : The human BTG2 gene is one of five members of a newly identified family of antiproliferative genes. BTG2 was first described as an immediate early gene whose expression is induced in response to mitogenic as well as differentiative and antiproliferative factors. More recently, we have shown that BTG2 expression is also induced in response to genotoxic stress through a p53-dependent mechanism. Experimental overexpression of the BTG2 gene in NIH3T3 and PC12 cells leads to a partial inhibition of cell proliferation. BTG2 protein physically interacts with Caf1 protein, an element of a general transcription complex, and with PRMT1, a protein-arginine N-methyl transferase. We speculate on the role of BTG2 as a modulator of the intracellular signal transduction cascade.

Keywords :

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]